Pharmaceuticals

Moderna Faces Challenges, MRNA Stock Continues YTD Decline

Moderna faces challenges with declining sales and pipeline delays, raising concerns for investors as it navigates its 2025 outlook in a shifting market.

SelectQuote Reports Impressive Q2 Growth

SelectQuote's Q2 FY2025 performance highlights significant revenue growth, soaring net income, and strategic investments, reinforcing its market strength and potential.

Shares Soar as GH Research Unveils Promising Drug Trial

GH Research PLC's stock soared 89% after promising results for GH001, an innovative therapy for treatment-resistant depression. Explore the potential.

Thermo Fisher Posts Strong Q4 Earnings Boosting Stock

Thermo Fisher Scientific's Q4 results show increased earnings and revenue, with strong product launches and a positive outlook for future growth.

Akero (AKRO) Stock Surges on Promising Drug Results

Akero Therapeutics' efruxifermin shows promising results in treating liver cirrhosis, driving stock surges and revealing new investment prospects in biotech.

J&J Achieves Strong Q4 Performance

Johnson & Johnson's Q4 results reveal strong revenue growth, driven by Darzalex sales, and an optimistic outlook for 2025 amidst strategic acquisitions.

Intuitive Surgical Surpasses Q4 Expectations

Intuitive Surgical's Q4 revenue surged 25%, fueled by strong system placements. Analysts express optimism about future growth.

Bird Flu Risk Sparks Pharma Gains

The recent H5N1 bird flu death and rising seasonal flu cases create investment opportunities in pharmaceuticals and healthcare, highlighting pandemic preparedness.

Promising Results for Amgen's MariTide

Amgen's MariTide shows promising weight-loss results but faces competition and side effect challenges.

Merck Eyes Incyte for Possible Acquisition

Merck (MRK) is rumored to be pursuing Incyte (INCY), prompting market volatility.

Inside the Market Dominance of the Top 10 Pharma Giants

From innovation to influence. The world's biggest pharma players aren't just leaders. They're industry giants. This infographic shows their outsized impact.

Evotec Receives Takeover Bid from Halozyme (HALO)

Evotec has received a takeover offer from Halozyme, potentially creating a major player in life sciences. Retail investors should watch for market impacts.

NTRA Stock: Impressive Growth and Rising Profit Margins

Natera's impressive Q3 2024 highlights its strong position in the genetic testing market.

Global Fungal Outbreaks Surge

Fungal outbreaks are increasing globally, impacting health systems and creating new investment opportunities in antifungal research and treatments.

INGR Stock: Ingredion Targets Growth in Specialty Ingredients Market

Learn how specialty ingredients leader Ingredion is driving growth and targeting new markets in the consumer staples sector.